DCGI Directs To Recall Batches Of Rapid Antigen IVD Kits Of Labcare Diagnostics And SD Biosensor

Mumbai : The Drugs Controller General of India (DCGI) has directed all state licensing authorities (SLAs) to recall batches of rapid antigen in vitro diagnostic (IVD) kits of Gujarat-based manufacturer Labcare Diagnostics India Pvt Ltd and Haryana-based SD Biosensor Healthcare Pvt Ltd for non-compliance to the minimum acceptance criteria of sensitivity and specificity as stipulated by Indian Council of Medical Research (ICMR).

The said rapid antigen IVD kits have been found to be non-conforming to the requirements as prescribed under Rule 7 of Medical Device Rules (MDR)-2017 especially in COVID -19 pandemic situations.

Therefore, in public interest, SLAs have been directed to inform all to whom the batch manufactured by the two manufacturers has been distributed or supplied to stop further use of it and also to recall the same with immediate effect. Compliance in this regard shall be submitted to the DCGI office for the said lot.

Labcare and SD Biosensor are holding license to manufacture and sale and distribution of IVD Antigen Lateral Flow Test.

DCGI had on July 17, 2020 canceled kit import licences of three firms and suspended those of 15 others citing a ban by the US government due to quality compliance issues.

Companies go through three batches of ICMR trials before the agency sends their validation to the Director Controller General of India for final approval. If a test kit already has USFDA approval, it skips ICMR validation for DCGI approval.

In mid-March, the US FDA allowed test kits with external validation to bypass their validation process. After US Congress committee findings criticised their leniency, they began cracking down on “poor performance or misleading statements” and began publishing “removed” manufacturers on May 21, 2020.

When ICMR banned several Chinese antibody kits, the Indian Ambassador to South Korea visited SD Biosensor’s facility on April 22 to facilitate a shift to South Korean brands. Biosensor was also the first company to sell the heavily-used antigen test kits in India.

Related Posts

  • Pharma
  • March 27, 2024
  • 104 views
Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

  • Pharma
  • March 27, 2024
  • 69 views
DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Lee Health develops natural capsule for effective Heart care

Lee Health develops natural capsule for effective Heart care

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down